⌘K

Home/Filings/4/0000950170-23-031855

4//SEC Filing

Dion Gisele 4

Accession 0000950170-23-031855

CIK 0001750149other

View on SEC.gov Company Profile

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 9:16 PM ET

Size

5.1 KB

Accession

0000950170-23-031855

Insider Transaction Report

Form 4

Period: 2023-06-30

Inhibikase Therapeutics, Inc.IKT

Director

Transactions

Award
Stock Option (right to buy)
2023-06-30+6,667→ 6,667 total
Exercise: $3.61Exp: 2030-06-30→ Common Stock (6,667 underlying)

Footnotes (1)

[F1]The options will vest on the earlier of June 30, 2024 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Inhibikase Therapeutics, Inc.

CIK 0001750149

Entity typeother

Related Parties

1

filerCIK 0001873088

Filing Metadata

Form type: 4
Filed: Jul 4, 8:00 PM ET
Accepted: Jul 5, 9:16 PM ET
Size: 5.1 KB

View on SEC.gov